Eli Lilly's Weight Loss Pill Prescriptions Reach 1,390 in First Week of Sales
Eli Lilly's new weight loss drug, Foundayo, received 1,390 prescriptions in its first week of sales, according to IQVIA data cited by Reuters. The drug, a GLP-1 product, was launched earlier this month by the Indiana-based pharmaceutical company. The number of prescriptions highlights early market adoption of the drug.
Topics: Eli Lilly Foundayo GLP-1 prescriptions weight loss pill